1. Home
  2. BPRN vs DSGN Comparison

BPRN vs DSGN Comparison

Compare BPRN & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPRN
  • DSGN
  • Stock Information
  • Founded
  • BPRN 2007
  • DSGN 2017
  • Country
  • BPRN United States
  • DSGN United States
  • Employees
  • BPRN N/A
  • DSGN N/A
  • Industry
  • BPRN Major Banks
  • DSGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BPRN Finance
  • DSGN Health Care
  • Exchange
  • BPRN Nasdaq
  • DSGN Nasdaq
  • Market Cap
  • BPRN 217.9M
  • DSGN 208.9M
  • IPO Year
  • BPRN N/A
  • DSGN 2021
  • Fundamental
  • Price
  • BPRN $30.95
  • DSGN $6.23
  • Analyst Decision
  • BPRN Strong Buy
  • DSGN
  • Analyst Count
  • BPRN 1
  • DSGN 0
  • Target Price
  • BPRN $35.00
  • DSGN N/A
  • AVG Volume (30 Days)
  • BPRN 9.8K
  • DSGN 175.1K
  • Earning Date
  • BPRN 10-28-2025
  • DSGN 11-06-2025
  • Dividend Yield
  • BPRN 3.90%
  • DSGN N/A
  • EPS Growth
  • BPRN N/A
  • DSGN N/A
  • EPS
  • BPRN 1.00
  • DSGN N/A
  • Revenue
  • BPRN $68,942,000.00
  • DSGN N/A
  • Revenue This Year
  • BPRN $13.82
  • DSGN N/A
  • Revenue Next Year
  • BPRN $15.85
  • DSGN N/A
  • P/E Ratio
  • BPRN $30.78
  • DSGN N/A
  • Revenue Growth
  • BPRN N/A
  • DSGN N/A
  • 52 Week Low
  • BPRN $27.25
  • DSGN $2.60
  • 52 Week High
  • BPRN $39.35
  • DSGN $7.77
  • Technical
  • Relative Strength Index (RSI)
  • BPRN 40.72
  • DSGN 52.82
  • Support Level
  • BPRN $30.67
  • DSGN $5.88
  • Resistance Level
  • BPRN $32.95
  • DSGN $7.59
  • Average True Range (ATR)
  • BPRN 0.62
  • DSGN 0.50
  • MACD
  • BPRN -0.17
  • DSGN -0.06
  • Stochastic Oscillator
  • BPRN 11.40
  • DSGN 27.49

About BPRN Princeton Bancorp Inc. (PA)

Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

Share on Social Networks: